These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 35033828)

  • 21. Quantification and utility of monosialylated alpha-fetoprotein in the diagnosis of hepatocellular carcinoma with nondiagnostic serum total alpha-fetoprotein.
    Poon TC; Mok TS; Chan AT; Chan CM; Leong V; Tsui SH; Leung TW; Wong HT; Ho SK; Johnson PJ
    Clin Chem; 2002 Jul; 48(7):1021-7. PubMed ID: 12089170
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Novel Blood-Based Panel of Methylated DNA and Protein Markers for Detection of Early-Stage Hepatocellular Carcinoma.
    Chalasani NP; Ramasubramanian TS; Bhattacharya A; Olson MC; Edwards V DK; Roberts LR; Kisiel JB; Reddy KR; Lidgard GP; Johnson SC; Bruinsma JJ
    Clin Gastroenterol Hepatol; 2021 Dec; 19(12):2597-2605.e4. PubMed ID: 32889146
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of prothrombin induced by vitamin K absence, macrophage migration inhibitory factor and Golgi protein-73 versus alpha fetoprotein for hepatocellular carcinoma diagnosis and surveillance.
    Ismail MM; Morsi HK; Abdulateef NA; Noaman MK; Abou El-Ella GA
    Scand J Clin Lab Invest; 2017 May; 77(3):175-183. PubMed ID: 28276727
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Research progress of AFP in the diagnosis and therapy of hepatocellular carcinoma].
    Qian L; Li C; Luo Y; Meng S
    Sheng Wu Gong Cheng Xue Bao; 2021 Sep; 37(9):3042-3060. PubMed ID: 34622616
    [TBL] [Abstract][Full Text] [Related]  

  • 25. VWF/ADAMTS13 ratio as a potential biomarker for early detection of hepatocellular carcinoma.
    Takaya H; Namisaki T; Kitade M; Kaji K; Nakanishi K; Tsuji Y; Shimozato N; Moriya K; Seki K; Sawada Y; Saikawa S; Sato S; Kawaratani H; Akahane T; Noguchi R; Matsumoto M; Yoshiji H
    BMC Gastroenterol; 2019 Oct; 19(1):167. PubMed ID: 31638892
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Potential Serum
    Higashi M; Yoshimura T; Usui N; Kano Y; Deguchi A; Tanabe K; Uchimura Y; Kuriyama S; Suzuki Y; Masaki T; Ikenaka K
    Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33255418
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Application of alpha-fetoprotein and osteopontin combination for early diagnosis of hepatocellular carcinoma associated with hepatitis C.].
    Malov SI; Malov IV; Dvornichenko VV; Rasulov RI; Kuvshinov AG; Marche PN; Decaens T; Macek-Jilkova Z; Yushchuk ND
    Klin Lab Diagn; 2019; 64(10):607-612. PubMed ID: 31742954
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhanced detection of early hepatocellular carcinoma by serum SELDI-TOF proteomic signature combined with alpha-fetoprotein marker.
    Chen L; Ho DW; Lee NP; Sun S; Lam B; Wong KF; Yi X; Lau GK; Ng EW; Poon TC; Lai PB; Cai Z; Peng J; Leng X; Poon RT; Luk JM
    Ann Surg Oncol; 2010 Sep; 17(9):2518-25. PubMed ID: 20354800
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Usefulness of serum alpha-fetoprotein (AFP) as a marker for hepatocellular carcinoma (HCC) in hepatitis C virus related cirrhosis: analysis of the factors influencing AFP elevation without HCC development].
    Kim KA; Lee JS; Jung ES; Kim JY; Bae WK; Kim NH; Moon YS
    Korean J Gastroenterol; 2006 Nov; 48(5):321-6. PubMed ID: 17132920
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Significance of Glypican-3 in Early Detection of Hepatocellular Carcinoma in Cirrhotic Patients.
    Tahon AM; El-Ghanam MZ; Zaky S; Emran TM; Bersy AM; El-Raey F; A Z E; El Kharsawy AM; Johar D
    J Gastrointest Cancer; 2019 Sep; 50(3):434-441. PubMed ID: 29623600
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PIVKA-II serves as a potential biomarker that complements AFP for the diagnosis of hepatocellular carcinoma.
    Feng H; Li B; Li Z; Wei Q; Ren L
    BMC Cancer; 2021 Apr; 21(1):401. PubMed ID: 33849479
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Expressions of CD44, CD90 and Alpha Fetoprotein Biomarkers in Indonesian Patients with Advanced Liver Disease: an Observational Study.
    Mustika S; Wijaya H; Pratomo B
    Acta Med Indones; 2019 Apr; 51(2):137-144. PubMed ID: 31383828
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Serum anti-Ku86: a potential biomarker for early detection of hepatocellular carcinoma].
    Chu L; Zhang X; Wang G; Zhou W; Du Z; Liu A; Zhao H
    Zhonghua Zhong Liu Za Zhi; 2014 Feb; 36(2):123-7. PubMed ID: 24796461
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Role of Dermcidin in the Diagnosis and Staging of Hepatocellular Carcinoma.
    Qiu F; Qiu F; Liu L; Liu J; Xu J; Huang X
    Genet Test Mol Biomarkers; 2018 Apr; 22(4):218-223. PubMed ID: 29641283
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluating patients with cirrhosis for hepatocellular carcinoma: value of clinical symptomatology, imaging and alpha-fetoprotein.
    Paul SB; Gulati MS; Sreenivas V; Madan K; Gupta AK; Mukhopadhyay S; Acharya SK
    Oncology; 2007; 72 Suppl 1():117-23. PubMed ID: 18087192
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human telomerase reverse transcriptase messenger RNA (TERT mRNA) as a tumour marker for early detection of hepatocellular carcinoma.
    El-Mazny A; Sayed M; Sharaf S
    Arab J Gastroenterol; 2014 Jun; 15(2):68-71. PubMed ID: 25097049
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection of Alpha-Fetoprotein in Hepatocellular Carcinoma Patient Plasma with Graphene Field-Effect Transistor.
    Kim DH; Oh HG; Park WH; Jeon DC; Lim KM; Kim HJ; Jang BK; Song KS
    Sensors (Basel); 2018 Nov; 18(11):. PubMed ID: 30463232
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biosensing of Alpha-Fetoprotein: A Key Direction toward the Early Detection and Management of Hepatocellular Carcinoma.
    Ramachandran L; Abul Rub F; Hajja A; Alodhaibi I; Arai M; Alfuwais M; Makhzoum T; Yaqinuddin A; Al-Kattan K; Assiri AM; Broering DC; Chinnappan R; Mir TA; Mani NK
    Biosensors (Basel); 2024 May; 14(5):. PubMed ID: 38785709
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of squamous cell carcinoma antigen-immunoglobulin M complex (SCCA-IGM) and alpha-L-fucosidase (AFU) as novel diagnostic biomarkers for hepatocellular carcinoma.
    Mossad NA; Mahmoud EH; Osman EA; Mahmoud SH; Shousha HI
    Tumour Biol; 2014 Nov; 35(11):11559-64. PubMed ID: 25129443
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Elevated alpha-fetoprotein: differential diagnosis - hepatocellular carcinoma and other disorders.
    Wong RJ; Ahmed A; Gish RG
    Clin Liver Dis; 2015 May; 19(2):309-23. PubMed ID: 25921665
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.